Cancer survivor toasts new life with sweet biz (New York Daily News)
Two bouts of self-examination changed David Luks' life. The second might not be bad for his wallet, either.
Read more...
Panel: EPA must consider effects of chemical barrage (USA Today)
Chemicals that interfere with the male hormone system are so common and so potentially damaging that the government should stop studying them one by one and consider their combined effect, an expert panel said Thursday.
Read more...
Is face transplant worth risking patient's life? (MSNBC)
When face transplants were first proposed 10 years ago I thought they were unethical. But with advances and the first U.S. face transplant, I no longer so, writes bioethicist Art Caplan
Read more...
ZIOPHARM Presents Positive Darinaparsin Phase II Data At ASH Meeting (Medical News Today)
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that on December 6th it presented positive data from a Phase II study of darinaparsin (ZinaparTM) for the treatment of advanced lymphomas at the 50th American Society of Hematology (ASH) Annual Meeting held in San Francisco, CA.
Read more...
Texas Oncology Says "Be Smart, Know Your Genetic Risk" Genetic Testing Saves Lives
Read more...
|